Endoscopy is performed to check for abnormal growth of abdominal pain, ulcers, gut bleeding, bowel and other abdominal and gastrointestinal conditions. This is one of the most preferred and necessary procedures in diagnosis and surgery because of the low incidence of postoperative complications.

The spread of diseases that require endocrine treatment procedures such as cancer and gastroenteritis is one of the important reasons driving the growth of the endocrine device market. Patient preference for increased infant boom generation increased awareness of new endocrine therapies, and minimal invasiveness of endocrine devices will also drive market growth.


Download sample copy @ https://www.alliedmarketresearch.com/request-sample/4648


The Asia-Pacific endotherapy devices market accounted for $826 million in 2017, and is expected to reach $1,315 million by 2024, registering a CAGR of 6.9% from 2018 to 2024. Japan was the highest contributor in the Asia-Pacific endotherapy devices market in 2017; however, China is expected to witness the highest growth rate during the forecast period.

Modern endoscopic therapy techniques have revolutionized the examination and treatment of upper gastrointestinal tract (including esophagus, stomach, and duodenum) and colon. Increased adoption of innovative endoscope devices with ultra-high-density visualization systems further increases market growth. However, market growth is hampered by the lack of skilled physicians and endoscopy testers, the high cost of sophisticated endoscopic devices, and infections caused by some endocrine devices.

Major Companies:

• Hoya Corporation
• Olympus Corporation
• Stryker Corporation
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Conmed Corporation Medtronic Plc.


Key Findings of the Asia-Pacific Endotherapy Devices Market:

• ERCP devices and accessories are expected to grow at the highest rate during the analysis period.

• Japan has dominated the Asia-Pacific endoscope market in 2017 and is expected to continue to dominate the market in the future.

• Guidewire is expected to grow at the highest rate in the Asia Pacific region during the forecast period.

• Graspers made the biggest contribution to GI devices and consumables in 2017.

• The end cap has generated the highest revenue in 2017 and is expected to continue to gain strength in the future.


Send enquiry us @ https://www.alliedmarketresearch.com/purchase-enquiry/4648

About Us:


Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.